These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

898 related items for PubMed ID: 22551023

  • 1. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
    Goldstone SE, Vuocolo S.
    Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
    [Abstract] [Full Text] [Related]

  • 2. The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine gardasil.
    Haupt RM, Sings HL.
    J Adolesc Health; 2011 Nov; 49(5):467-75. PubMed ID: 22018560
    [Abstract] [Full Text] [Related]

  • 3. 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.
    Pitisuttithum P, Velicer C, Luxembourg A.
    Expert Rev Vaccines; 2015 Nov; 14(11):1405-19. PubMed ID: 26366475
    [Abstract] [Full Text] [Related]

  • 4. The HPV infection in males: an update.
    Giraldi G, De Luca d'Alessandro E.
    Ann Ig; 2012 Nov; 24(6):497-506. PubMed ID: 23234187
    [Abstract] [Full Text] [Related]

  • 5. Gardasil: Introducing the new human papillomavirus vaccine.
    McLemore MR.
    Clin J Oncol Nurs; 2006 Oct; 10(5):559-60. PubMed ID: 17063609
    [Abstract] [Full Text] [Related]

  • 6. Epidemiology and natural history of genital human papillomavirus infection.
    Weaver BA.
    J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S2-8. PubMed ID: 16729554
    [Abstract] [Full Text] [Related]

  • 7. HPV vaccine update: new indications and controversies.
    Mendoza N, Hernandez PO, Tyring SK.
    Skin Therapy Lett; 2011 Sep; 16(8):1-3. PubMed ID: 22089414
    [Abstract] [Full Text] [Related]

  • 8. Developing an HPV vaccine to prevent cervical cancer and genital warts.
    Bryan JT.
    Vaccine; 2007 Apr 20; 25(16):3001-6. PubMed ID: 17289220
    [Abstract] [Full Text] [Related]

  • 9. Prophylactic HPV vaccines: new interventions for cancer control.
    Barr E, Sings HL.
    Vaccine; 2008 Nov 18; 26(49):6244-57. PubMed ID: 18694795
    [Abstract] [Full Text] [Related]

  • 10. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
    Broomall EM, Reynolds SM, Jacobson RM.
    Postgrad Med; 2010 Mar 18; 122(2):121-9. PubMed ID: 20203463
    [Abstract] [Full Text] [Related]

  • 11. [The first vaccine against cancer: the human papillomavirus vaccine].
    Bősze P.
    Orv Hetil; 2013 Apr 21; 154(16):603-18. PubMed ID: 23587540
    [Abstract] [Full Text] [Related]

  • 12. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
    Guo T, Eisele DW, Fakhry C.
    Cancer; 2016 Aug 01; 122(15):2313-23. PubMed ID: 27152637
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer.
    Chelimo C, Wouldes TA, Cameron LD, Elwood JM.
    J Infect; 2013 Mar 01; 66(3):207-17. PubMed ID: 23103285
    [Abstract] [Full Text] [Related]

  • 14. 9-Valent human papillomavirus vaccine: a review of the clinical development program.
    Luxembourg A, Moeller E.
    Expert Rev Vaccines; 2017 Nov 01; 16(11):1119-1139. PubMed ID: 28956458
    [Abstract] [Full Text] [Related]

  • 15. Post-licensure monitoring of HPV vaccine in the United States.
    Markowitz LE, Hariri S, Unger ER, Saraiya M, Datta SD, Dunne EF.
    Vaccine; 2010 Jul 05; 28(30):4731-7. PubMed ID: 20188681
    [Abstract] [Full Text] [Related]

  • 16. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
    Dunne EF, Datta SD, E Markowitz L.
    Cancer; 2008 Nov 15; 113(10 Suppl):2995-3003. PubMed ID: 18980283
    [Abstract] [Full Text] [Related]

  • 17. [The disease burden of human papillomavirus in men is substantial and can potentially be prevented].
    Kiellberg Larsen H, Kofoed K, Sand C.
    Ugeskr Laeger; 2013 Feb 04; 175(6):349-53. PubMed ID: 23402241
    [Abstract] [Full Text] [Related]

  • 18. A human papillomavirus vaccine.
    Med Lett Drugs Ther; 2013 Feb 04; 48(1241-1242):65-6. PubMed ID: 16977280
    [Abstract] [Full Text] [Related]

  • 19. Quadrivalent human papillomavirus vaccine.
    Barr E, Tamms G.
    Clin Infect Dis; 2007 Sep 01; 45(5):609-7. PubMed ID: 17682997
    [Abstract] [Full Text] [Related]

  • 20. Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study.
    Brisson M, Laprise JF, Drolet M, Van de Velde N, Franco EL, Kliewer EV, Ogilvie G, Deeks SL, Boily MC.
    Vaccine; 2013 Aug 20; 31(37):3863-71. PubMed ID: 23830974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.